Olanzapine for The Prevention of Nausea and Vomiting Caused by Chemoradiotherapy with High-Dose Cisplatin for Head and Neck Cancer-Reference-Cited by-同舟云学术

Olanzapine for The Prevention of Nausea and Vomiting Caused by Chemoradiotherapy with High-Dose Cisplatin for Head and Neck Cancer

Published:2023 Issue:2 Volume:66 Page:208-213
ISSN:1346-8049
Container-title:Yonago Acta Medica
language:en
Short-container-title:Yonago Acta Med.

Author:

Koyama Satoshi¹,Ehara Hiroaki¹,Donishi Ryohei¹,Morisaki Tsuyoshi¹,Taira Kenkichiro¹,Fukuhara Takahiro¹,Fujiwara Kazunori¹

Affiliation:

1. Division of Otolaryngology, Head and Neck Surgery, Department of Sensory and Motor Organs, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan

Publisher

Tottori University Faculty of Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/yam/66/2/66_2023.05.002/_pdf

Reference14 articles.

1. 1. Ng TL, Hutton B, Clemons M. Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea? Oncologist. 2015;20:576-83. PMID:25948677, DOI:10.1634/theoncologist.2014-0438

2. 2. Navari RM. Management of chemotherapy-induced nausea and vomiting : focus on newer agents and new uses for older agents. Drugs. 2013;73:249-62. PMID:23404093, DOI:10.1007/s40265-013-0019-1

3. 3. Hashimoto H, Abe M, Tokuyama O, Mizutani H, Uchitomi Y, Yamaguchi T, et al. Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020;21:242-9. PMID:31838011, DOI:10.1016/S1470-2045(19)30678-3

4. 4. Navari RM, Qin R, Ruddy KJ, Liu H, Powell SF, Bajaj M, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;375:134-42. PMID:27410922, DOI:10.1056/NEJMoa1515725

5. 5. Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, et al. Antiemetics: ASCO Guideline Update. J Clin Oncol. 2020;38:2782-97. PMID:32658626, DOI:10.1200/JCO.20.01296